RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,495 | +14.7% | 11,028 | +59.9% | 0.00% | – |
| Q2 2023 | $8,275 | -93.8% | 6,896 | -54.5% | 0.00% | – |
| Q1 2023 | $132,560 | +281.8% | 15,167 | +249.5% | 0.00% | – |
| Q4 2022 | $34,720 | -63.8% | 4,340 | -78.0% | 0.00% | – |
| Q3 2022 | $96,000 | -57.0% | 19,716 | -50.9% | 0.00% | – |
| Q2 2022 | $223,000 | -26.2% | 40,184 | -32.6% | 0.00% | – |
| Q1 2022 | $302,000 | -58.9% | 59,591 | +4.4% | 0.00% | – |
| Q4 2021 | $735,000 | +21.7% | 57,085 | +41.4% | 0.00% | – |
| Q3 2021 | $604,000 | +3255.6% | 40,379 | +3442.0% | 0.00% | – |
| Q2 2021 | $18,000 | – | 1,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |